Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial ResultsPRNewsWire • 05/13/21
Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 VaccinesSeeking Alpha • 05/10/21
Galmed Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Business Update on Thursday May 13PRNewsWire • 05/06/21
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational StudyPRNewsWire • 05/03/21
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/18/21
Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial ResultsPRNewsWire • 03/18/21
Galmed Pharmaceuticals Announces Dosing of First Subject in First in Human Phase 1 Trial of Amilo-5MERPRNewsWire • 03/16/21
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2020 Financial Results and Provide Business Update on Thursday March 18PRNewsWire • 03/11/21
Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol's Novel Anti-Fibrotic Mechanism of ActionPRNewsWire • 01/26/21
Galmed to add Open Label Part to ARMOR Study; First Read-out Expected in Q4 2021PRNewsWire • 12/17/20
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/12/20
Galmed and Gannex Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)PRNewsWire • 09/10/20
Gannex and Galmed Expand Development Programs For NASH Through Research Collaboration of Aramchol and ASC41 (THR-beta Agonist)PRNewsWire • 09/09/20
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Galmed Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsPRNewsWire • 08/06/20
Galmed Pharmaceuticals Announces Acceleration of its New Clinical Amilo-5MER programPRNewsWire • 08/06/20
Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2020 Financial ResultsPRNewsWire • 05/14/20
Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/12/20
Galmed Pharmaceuticals Ltd (GLMD) CEO Allen Baharaff on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/10/19